Development of a human skin commensal microbe for bacteriotherapy of atopic dermatitis and use in a phase 1 randomized clinical trial
Author(s) -
Teruaki Nakatsuji,
Tissa Hata,
Yun Tong,
J Cheng,
Faiza Shafiq,
Anna M. Butcher,
Secilia S. Salem,
Samantha L. Brinton,
Amanda K. Rudman Spergel,
Keli Johnson,
Brett Jepson,
Agustin Calatroni,
Gloria L. David,
Marco Ramírez-Gama,
Patricia A. Taylor,
Donald Y.M. Leung,
Richard L. Gallo
Publication year - 2021
Publication title -
nature medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.536
H-Index - 547
eISSN - 1546-170X
pISSN - 1078-8956
DOI - 10.1038/s41591-021-01256-2
Subject(s) - atopic dermatitis , staphylococcus aureus , medicine , adverse effect , randomized controlled trial , proinflammatory cytokine , clinical endpoint , skin infection , immunology , dermatology , inflammation , microbiology and biotechnology , biology , bacteria , genetics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom